1975
DOI: 10.1177/000992287501400201
|View full text |Cite
|
Sign up to set email alerts
|

Streptococcal Pharyngitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1983
1983
2007
2007

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Several studies have demonstrated that clindamycin and its parent compound, lincomycin, are successful in the treatment of recurrent streptococcal illness or the strep tococcal carrier state [14][15][16], possibly due to their effectiveness against GABHS and bcta-lactamase-producing aerobic and an aerobic organisms in the tonsillar tissue. Further studies of the protective effects of other beta-lactamase-producing Bacteroides strains present in tonsillar tissue will clarify also their influence on the response to peni cillin.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have demonstrated that clindamycin and its parent compound, lincomycin, are successful in the treatment of recurrent streptococcal illness or the strep tococcal carrier state [14][15][16], possibly due to their effectiveness against GABHS and bcta-lactamase-producing aerobic and an aerobic organisms in the tonsillar tissue. Further studies of the protective effects of other beta-lactamase-producing Bacteroides strains present in tonsillar tissue will clarify also their influence on the response to peni cillin.…”
Section: Discussionmentioning
confidence: 99%